Cargando…
Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19”
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471533/ https://www.ncbi.nlm.nih.gov/pubmed/32880807 http://dx.doi.org/10.1007/s40265-020-01395-9 |
_version_ | 1783578788044472320 |
---|---|
author | Vrachatis, Dimitrios A. Giotaki, Sotiria G. Giannopoulos, George Deftereos, Spyridon Reimers, Bernhard |
author_facet | Vrachatis, Dimitrios A. Giotaki, Sotiria G. Giannopoulos, George Deftereos, Spyridon Reimers, Bernhard |
author_sort | Vrachatis, Dimitrios A. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7471533 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-74715332020-09-04 Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19” Vrachatis, Dimitrios A. Giotaki, Sotiria G. Giannopoulos, George Deftereos, Spyridon Reimers, Bernhard Drugs Letter to the Editor Springer International Publishing 2020-09-03 2020 /pmc/articles/PMC7471533/ /pubmed/32880807 http://dx.doi.org/10.1007/s40265-020-01395-9 Text en © Springer Nature Switzerland AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Letter to the Editor Vrachatis, Dimitrios A. Giotaki, Sotiria G. Giannopoulos, George Deftereos, Spyridon Reimers, Bernhard Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19” |
title | Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19” |
title_full | Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19” |
title_fullStr | Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19” |
title_full_unstemmed | Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19” |
title_short | Comment on: “Pharmaco-Immunomodulatory Therapy in COVID-19” |
title_sort | comment on: “pharmaco-immunomodulatory therapy in covid-19” |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471533/ https://www.ncbi.nlm.nih.gov/pubmed/32880807 http://dx.doi.org/10.1007/s40265-020-01395-9 |
work_keys_str_mv | AT vrachatisdimitriosa commentonpharmacoimmunomodulatorytherapyincovid19 AT giotakisotiriag commentonpharmacoimmunomodulatorytherapyincovid19 AT giannopoulosgeorge commentonpharmacoimmunomodulatorytherapyincovid19 AT deftereosspyridon commentonpharmacoimmunomodulatorytherapyincovid19 AT reimersbernhard commentonpharmacoimmunomodulatorytherapyincovid19 |